The Patented Solid Solution for cfDNA Purification 
Innovative Magnet / Sleeve Designs

     NeoGeneStar

The

FDA authorized under EUA AccessBio Covid-19 Rapid Antigen Test Kit
Rapid test, results are read AT ten minutes
Nasopharyngeal swab specimen collection
Detects SARS-CoV-2 nucleocapsid protein antigen via a lateral flow
  • This product has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories; 
  • This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and 
  • The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

FDA EUA Abbott's BinaxNOW COVID-19 Rapid Antigen Test Card

First at-home, virtually guided service

15-minute antigen test 

No instrument need

IFU

FDA Emergency Authorization Letter

Fact Sheet for Healthcare Providers

Fact Sheet for Patients

AMPER COVID-19 Antigen Rapid Testing Kit

FDA EUA submitted

No lab equipment or additional instrument required
Nasopharyngeal swab specimen collection
Detects SARS-CoV-2 nucleocapsid protein antigen 
via a lateral flow assay
AMPER COVID-19 Antigen Rapid Testing Kit IFU

Contact Information:


Mail:                NeoGeneStar LLC

                          100 Randolph Road,  Suite  2B

                          Somerset,  NJ   08873 

                          USA 

Phones:         (732) 421-4567

Fax:                (908) 756-4483

Email:      NeoGeneStar@gmail.com    

General: Info@NeoGeneStar.com

Technical support: Tech@NeoGeneStar.com

Business Development: BD@NeoGeneStar.com

Place orders: Order@NeoGeneStar.com